The Canada pharmaceutical market size and share is currently valued at USD 48.62 billion in 2023. It is anticipated to generate an estimated revenue of USD 88.11 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024-2032. The key market players include AbbVie, AstraZeneca, Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson,
/PRNewswire/ The "Checkpoint Inhibitors Global Market Report 2024" has been added to ResearchAndMarkets.com s offering. The latest comprehensive research on.
/PRNewswire/ The "Cancer Clinical Decision Tools Global Market Report 2024" report has been added to ResearchAndMarkets.com s offering. Unveiling the latest.
Arthralgia Management marketFuture Market Insights projects that the arthritis management market growth will increase at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2033. It is anticipated that the global market for Arthralgia Management would reach a market worth of US$ 15.5 billion by 2033. The marke.